Neptune Digital Assets Corp. (TSXV:NDA)

Sage Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Market Capitalization	150	32	31	29	69	6
Market Cap Growth	442.50%	1.36%	9.24%	-58.18%	966.75%	13.99%
Enterprise Value	147	16	17	28	68	6
Last Close Price	1.18	0.25	0.25	0.23	0.55	0.07
PE Ratio	-	13.10	-	-	-	39.52
Forward PE	-	-	8.30	8.30	-	-
PS Ratio	81.34	13.21	10.81	6.85	191.53	-
PB Ratio	2.02	0.64	0.97	0.82	1.27	1.81
P/TBV Ratio	2.02	0.64	0.97	0.82	1.27	1.81
EV/Sales Ratio	79.82	6.49	5.96	6.56	188.67	-
EV/EBITDA Ratio	-	-	-	22.56	-	-
EV/EBIT Ratio	-	-	-	112.99	-	-
Debt / Equity Ratio	0.10	-	-	-	-	-
Asset Turnover	0.03	0.06	0.08	0.09	0.01	-
Quick Ratio	1.40	15.54	22.68	10.73	19.06	2.51
Current Ratio	1.40	15.54	23.21	29.90	59.52	6.31
Return on Equity (ROE)	-0.89%	5.91%	-15.20%	-47.32%	-2.06%	5.30%
Return on Assets (ROA)	-2.08%	-2.81%	-3.82%	0.34%	-14.99%	-8.59%
Return on Capital (ROIC)	-2.09%	-2.86%	-3.91%	0.34%	-15.25%	-9.09%
Return on Capital Employed (ROCE)	-	-	-	0.70%	-	-
Earnings Yield	-0.39%	7.64%	-16.33%	-73.35%	-0.86%	2.53%
FCF Yield	-	-9.61%	-10.86%	-15.81%	-1.47%	-5.72%
Buyback Yield / Dilution	-0.52%	-2.65%	-0.13%	-21.87%	-23.69%	-2.93%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.